Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
874
Sort by:
COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020. Including: 1) By Product Type: Small Molecules, Biologics, Blood & Plasma Derivatives, Monoclonal Antibodies, Vaccines, Others. 2) By Phase Of Development: Preclinical Therapeutics & Vaccines, Clinical Studies. 3) By Treatment Mechanism & Route Of Administration: Mechanism Of Action And By Route Of Administration. 4) By Type Of Sponsor: Pharma/Biotech Company, Academic Research/Institution, Others (such as Government Organizations and CROs). Covering: CanSino Biologics; Moderna; Inovio Pharmaceuticals; Regeneron; Gilead Sciences
US$ 4,000.00
COVID-19 Vaccine And Therapeutics Pipeline Analysis 2020 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess...
July 2020
200 pages
COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020. Including: 1) By Product Type: Small Molecules, Biologics, Blood & Plasma Derivatives, Monoclonal Antibodies, Vaccines, Others. 2) By Phase Of Development: Clinical Phase I (Active Trial & Discontinued Trials), Clinical Phase II (Active Trial & Discontinued Trials), Clinical Phase III (Active Trial & Discontinued Trials), Clinical Phase IV (Active Trial & Discontinued Trials). 3) By Route Of Administration: Oral, Intravenous, Subcutaneous, Other Route Of Administration. 4) By Type Of Sponsor: Pharma/Biotech Company, Academic Research/Institution, Others (such as Government Organizations and CROs). Covering: Pfizer; GlaxoSmithKline (GSK); Inovio Pharmaceuticals; Johnson & Johnson (J&J); Novavax Inc.
US$ 4,000.00
COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to ass...
July 2020
200 pages
Global DNA Vaccine Market Outlook 2022
US$ 1,800.00
... immune response. This comprehensive report by RNCOS entitled “Global DNA Vaccine Market Outlook 2022” provides an in-depth analysis of the global DNA Vaccines market, presenting readers a profound understanding of the various ...
June 2020
100 pages
Vaccines Market Research (China)
US$ 4,000.00
China's demand for Vaccines has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
May 2020
326 pages
Vaccines Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Vaccines industry forecasts. In the two past decades, the ... long-term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
May 2020
187 pages
Vaccines Companies in China
US$ 1,800.00
This study focuses on China’s Vaccines industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
May 2020
90 pages
Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020
US$ 1,290.00
“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market. The report offers the most u...
April 2020
135 pages
Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies
US$ 1,390.00
“Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Compani...
April 2020
165 pages
Global Dengue Vaccines Market Outlook 2027
US$ 4,150.00
Global Dengue Vaccine Market Analysis – 2018-2027 Dengue (also known as dengue fever) is a viral disease in humans transmitted by the mosquitoes of genus Aedes, and are divided into four serotypes, wh...
March 2020
60 pages
Vaccines Market by Indication, Route of Administration, Type/Antigen, Valence - Global Forecast to 2027
US$ 4,175.00
Vaccines Market by Indication (Influenza, Rotavirus, DTP Vaccines), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccine, Live Attenuated Vaccine), Valence (Mul...
February 2020
231 pages
Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2024
US$ 5,650.00
... share of the market in 2018.” Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment ... the vaccines market. It aims at estimating the market size and future growth potential of this market across different segments such as technology, type ...
January 2020
189 pages
International Trade in Antisera and Other Blood Fractions: Trends and Prospects
US$ 820.00
The reports examine global antisera and other blood fractions market trends (historical, current and forecast) with respect to international trade including antisera and other blood fractions global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
January 2020
170 pages
International Trade in Vaccines, Human Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, human use market trends (historical, current and forecast) with respect to international trade including vaccines, human use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
January 2020
90 pages
International Trade in Vaccines, Veterinary Use: Trends and Prospects
US$ 820.00
The reports examine global vaccines, veterinary use market trends (historical, current and forecast) with respect to international trade including vaccines, veterinary use global trade dynamics, exports/imports by geography, leading suppliers and consumers, average prices.
January 2020
90 pages
